Supply S-Equol/Equol/Finasteride Ru58841 Equol Setipiprant CAS 531-95-3
GMP ISO 2 Inquiries
531-95-3
Pharmaceutical Grade
99%
XAZB
Foil Bag
2022-12-31
Herb Extracts,Cosmetic raw materails,API
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
NameEquol
Synonyms(S)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol
CAS NO.531-95-3 Molecular Formula
C15H14O3 Molecular Weight
242.27 EINECS
208-522-2
AppearanceWhite Powder
Purity98% Min 
Equol is a selective estrogen receptor modulator that is produced by soybean isoflavone's metabolism which is
transformed by exclusively intestinal bacteria. This product has widely biological activities and has a beneficial effect
on many diseases, such as reduce the rate of coronary heart disease and atherosclerosis. besides, this product can
cure breast cancer, prostate cancer, prevent osteoporosis, improve the syndrome after menopause, protect nerves and
prevent aging. Research confirmed that equol can clear many kinds of free radicals, reduce the chain of DNA's breakage
significantly. It can be used in promoting the health of people who can not produce Equol in their bodies and preventing
disease, which has a bright future.
COAProduct Name:
Equol
Manufacture Date :
July.21.2021 CAS No.:
531-95-3
Expire Date:
July.21.2023
Shelf Life:
2 Year
Origin:
China
Items
Requirements
Results
Appearance:
White Powder
White Powder
Identification
HPLC
IR spectra is consistent with CRS
Conforms
Sulphated Ash
≤0.1%
0.01%
Loss on drying
≤0.1%
0.01% Related Material
Major ≤0.5%
Total ≤1.0%
0.3%
0.5%
Heavy metal
Pb :
Cadmium(Cd) :
As :
Hg:
≤ 10ppm
<1 ppm
<0.5 ppm
<10ppm
< 1 ppm
<10ppm
Conforms
0.3ppm
Conforms
Negative
Assay
≥98% 99.2% Conclusion:
The product conforms to BP.
Storage
Store in sealed containers in a cool & dry place.
Protect from light, moisture, and pest infestation.
Shelf Life
2 years when properly stored
Prostate enlargement
Dutasteride is occasionally used for treating benign prostatic hyperplasia (BPH); colloquially known as an "enlarged
prostate". It is approved by the Food and Drug Administration (FDA) in the U.S. for this indication.Pattern hair loss
Dutasteride is approved for the treatment of male androgenetic alopecia in South Korea at a dosage of 0.5 mg per day.
It has been found in several studies to improve hair growth in men more rapidly and to a greater extent than 2.5 mg/day
finasteride. Dutasteride has also been used off-label in the treatment of female pattern hair loss.Prostate cancer
In those who are being regularly screened, 5α-reductase inhibitors such as finasteride and dutasteride reduce the overall
risk of being diagnosed with prostate cancer; however, there is insufficient data to determine if they have an effect on the
risk of death and may increase the chance of more serious casesExcessive hair growth
Although no reports specific to dutasteride currently exist,5α-reductase inhibitors like finasteride have been found to be
effective in the treatment of hirsutism (excessive facial and/or body hair growth) in women. In a study of 89 women with
hyperandrogenism due to persistent adrenarche syndrome, finasteride produced a 93% reduction in facial hirsutism
and a 73% reduction in bodily hirsutism after 2 years of treatment. Other studies using finasteride for hirsutism have
also found it to be clearly effective.[2] Dutasteride may be more effective than finasteride for this indication due to the
fact that its inhibition of the 5α-reductase enzyme is comparatively more complete.
CertificatesBasic Info-
Product Name:
Equol
Other Name:2H-1-Benzopyran-7-ol,3,4-dihydro-3-(4-hydroxyphenyl)-,(3S)-;4′,7-Isoflavandiol;2H-1-Benzopyran-7-ol,3,4-dihydro-3-(4-hydroxyphenyl)-,(S)-;(3S)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol;4′,7-Dihydroxyisoflavan;Equol;(S)-(-)-4′,7-Isoflavandiol;Equol,(-)-;(-)-Equol;(-)-(S)-Equol;(S)-Equol;(3S)-Equol;SE 5OH;S-equol;AUS 131;(S)-(-)-Equol;(3S)-3-(4-Hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol;(S)-3-(4-Hydroxyphenyl)chroman-7-ol;20879-01-0
CAS No.:531-95-3
Molecular Formula:C15H14O3
InChIKeys:InChIKey=ADFCQWZHKCXPAJ-GFCCVEGCSA-N
Molecular Weight:242.27
Exact Mass:242.27
EC Number:208-522-2
UNII:2T6D2HPX7Q
DSSTox ID:DTXSID0022309
NCI Thesaurus Code:C120313
HScode:2932999099
Categories:
Characteristics-
PSA:
49.7
XLogP3:3
Appearance:Solid
Density:1.3±0.1 g/cm3
Melting Point:189.5 °C
Boiling Point:441.7°C at 760 mmHg
Flash Point:220.9±28.7 °C
Refractive Index:1.645
Water Solubility:72.3 mg/L @ 25 °C (est)
Storage Conditions:-20°C Freezer
Specific rotation:D -21.5°
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Herb Extracts,Cosmetic raw materails,API
-
Location:
1403,Jinye B Block
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
8
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
United Kingdom
Wuhan hhd Pharmaceutical Chemical Anti-hair loss 98% S-Equol CAS 531-95-3 in stock 99% white powder
1 KG Aug 25, 2023 
Russia
equol
10 KG Jun 25, 2025 Post an enquiry for this product